Get In Touch

Global Bacillus Anthracis Infections Market: Overview

Bacillus anthracis is a type of bacteria that causes an acute disease called anthrax. Bacillus anthracis can infect both animals and humans. Bacillus anthracis is able to form a bacterial spore and is able to survive for prolonged period of time, even for centuries, in any harsh and mild conditions. When the spores of Bacillus anthracis are inhaled, swallowed or adhered to a lesion, they get reactivated and start rapid multiplication in the body of host.

An important feature of Bacillus anthracis is it doesn’t spread from one person to another by direct contact. It gets spread by clothes, shoes and utensils used by infected person. The bacterium was discovered in 1876 by Robert Koch. The major symptoms of the disease are identified from cutaneous sites, gastrointestinal and pulmonary infections. Pulmonary infections such as, cold, flu, pneumonia and respiratory failure are considered as important indications for Bacillus anthracis infections. Whereas, major gastrointestinal symptoms include chronic GI pain, severe diarrhea and vomiting of blood. The anthrax caused to skin is also called as Hide Porter’s disease. This is very chronic and life-threatening disease in which the skin develops black center spotted boiled skin lesions. Although life-threatening, it does not cause any pain or sensation to patient, but gradually converts into necrotic ulcer. Diagnosis of Bacillus anthracis infection is done by gram test in laboratory, Ascoli test, PCR assays, chest CT scan and immunofluroscence microscopical diagnostic tests.

Global Bacillus Anthracis Infections Market: Major Segments

The market of Bacillus anthracis infection is segmented on the basis of treatments, such as, preventive treatment and disease treatment. Prevention treatment is divided into vaccines such as, Pasteur’s vaccine, Sterne’s vaccine, British anthrax vaccines, Russian Anthrax vaccines, and American anthrax vaccines (BioThrax) and prophylaxis care. Further, infection treatment include antibiotics (penicillin, ciprofloxacin, erythromycin, doxycycline and others), monoclonal antibodies, such as, Raxibacumab and others. Additionally, the market is segmented on the basis of geography, such as, North America, Europe, Asia-Pacific and Rest of the World (RoW). At present, North America and Europe are the most prominent markets, owing to growing prevalence of Bacillus anthracis infection and anthrax disease. However, Asia-Pacific and some countries in RoW region are expected to show very lucrative growth in the upcoming period, owing to rapidly growing prevalence and awareness about anthrax.

Global Bacillus Anthracis Infections Market: Drivers and Restraints

The market of Bacillus anthracis is expected to increase steadily during forecast period 2014 – 2020. This growth is anticipated to be driven by fatal nature of the disease, R&D practices to develop more efficient and specific drugs, rising awareness about the disease and use of anthrax spores for bioterrorism and bioweapons. Steadily growing prevalence and mortal nature of anthrax (although considered as orphan disease) are the most important drivers of this market. Since last few centuries, anthrax has killed millions of human and animal across the world. The mortality rate is around 80-85%. Further, due to rising threat of bio warfare and bioterrorism, this threat is expected to increase exponentially. Henceforth, the market is expected to grow at steady rate in the upcoming 5-10 years. Furthermore, due to R&D practices, a number of new formulations, such as, epimerox, CF-306, PMX-0231, PMX-225, EV-009 and many others are under pipeline studies and expected to enter in the market during forecast period 2014 – 2020. Entry of these formulations may propel the market growth to higher end. However, major hurdles include high cost of treatment and ignorance and false diagnosis of the symptoms, which may decrease the market growth to certain extent.

Global Bacillus Anthracis Infections Market: Companies Mentioned in the Report

Major players operating in the R&D practices and commercialization include ContraFect Corporation, Evolva SA, Aphios Corporation, Cellceutix Corporation and Microbiotix, Inc.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Bacillus Anthracis Infections Market